Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase - (patho)physiological and pharmacotherapeutical significance

   
Severina I.S.1

1. Institute of Biomedical Chemistry, Russian Academy of Medical Sciences
Section: Review
UDK: 577.152.6      PubMed Id: 18035720
Year: 2007  Volume: 53  Issue: 4  Pages: 385-399
The paper reviews the molecular mechanism underlying the physiological effects of nitric oxide (NO), the role of the signalling system: NO-soluble guanylate cyclase-cyclic 3',5'-guanosine monophosphate (cGMP) in the realization of NO action. The data concerning the basic chemical characteristics of guanylate cyclase, such as the subunits structure, isoforms, modern concepts of the catalytic and regulatory centers of the enzyme are presented. The role of guanylate cyclase heme and the enzyme itself in the realization of physiological effects of NO is demonstrated. The data concerning a new NO-independent, allosteric activator of soluble guanylate cyclase, YC-1 (benzyl indasol derivative) synergistically increased the NO-dependent activation of soluble guanylate cyclase are presented. The data on guanylate cyclase sites responsible for binding of the enzyme with YC-1 and possible molecular mechanism underlying the synergistic increase of NO-dependent activation of soluble guanylate cyclase by YC-1 are presented. New compounds of endogenous nature capable to potentiate and synergistically increase the activation of guanylate cyclase by NO-donors have been revealed and investigated. The important physiological, pharmacotherapeutical and pathophysiological significance of this new fact is discussed.
Download PDF:
Reference:

Severina I.S. (2007) Biomeditsinskaya khimiya, 53(4), 385-399.
This paper is also available as the English translation:10.1007/s11828-008-1002-3
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)
        

© Institute of Biomedical Chemistry, Moscow, Russia